Candel therapeutics to participate in guggenheim healthcare talks 2023 oncology day

Needham, mass., feb. 01, 2023 (globe newswire) -- candel therapeutics, inc. (nasdaq: cadl), a clinical stage biopharmaceutical company developing novel viral immunotherapies, today announced that paul peter tak, md, phd, fmedsci, president and chief executive officer, will participate in a fireside chat at the guggenheim 2023 healthcare talks oncology day taking place feb. 8 – 9, 2023, at the st. regis hotel in new york city. details are as follows:
CADL Ratings Summary
CADL Quant Ranking